US Patent Issued to Bayer, Dana-Farber Cancer Institute, The Broad Institute on Feb. 18 for "3-amino-2-[2-(acylamino)pyridin-4-yl-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-cpyridin-4-one as CSNK1 inhibitors" (German, American Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,501, issued on Feb. 18, was assigned to Bayer AG (Leverkusen, Germany), Dana-Farber Cancer Institute Inc. (Boston) and The Broad Institute Inc. (Cambridge, Mass.).

"3-amino-2-[2-(acylamino)pyridin-4-yl-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-cpyridin-4-one as CSNK1 inhibitors" was invented by Volker Schulze (Hohen Neuendorf, Germany), Anne Mengel (Berlin), Jens Schroder (Berlin), Adelaide Clara Faria Alvares De Lemos (Berlin), Wilhelm Bone (Berlin), Ulf Bomer (Berlin), Detlev Sulzle (Berlin), Clara Christ (Berlin), Roman Hillig (Berlin), Christian Lechner (Berlin), Steven Corsello (Boston), Katarzyna Handing (Framingham, Mass.), Alisha Caliman (Cambridge, Mass.), Ulrike Rauh (Berlin), S...